We also carried out an analysis of PSMC6 expression in ovarian carcinoma clinical specimens in which we observed that earlier stage disease tended to display higher PSMC6 levels, suggesting to explore approaches for targeting PSMC6 in early-stage tumors. The gene discussed is PSMC6; the disease is ovarian carcinoma.